Anti-Human CD326/EPCAM Antibody (3-17I)
The Anti-Human CD326/EPCAM Antibody (3-17I) is a highly specific and reliable tool for detecting and targeting the CD326/EPCAM protein in human cells. This antibody is produced using advanced biotechnology techniques, ensuring high purity and specificity for accurate results.
CD326/EPCAM, also known as Epithelial Cell Adhesion Molecule, is a transmembrane glycoprotein that plays a crucial role in cell adhesion and signaling. It is expressed in a variety of tissues, including epithelial cells, stem cells, and cancer cells. As a result, it has become an important biomarker for various biological processes and diseases.
The main applications of the Anti-Human CD326/EPCAM Antibody (3-17I) include flow cytometry, immunohistochemistry, and Western blotting. It is suitable for use in both research and clinical settings, providing valuable insights into the expression and function of CD326/EPCAM in different cell types and diseases.
In research, this antibody can be used to study the role of CD326/EPCAM in cell adhesion, proliferation, and differentiation. It can also aid in the identification and isolation of specific cell populations, such as circulating tumor cells. In clinical settings, the Anti-Human CD326/EPCAM Antibody (3-17I) can be used to diagnose and monitor various cancers, including breast, colon, and lung cancer.
One of the key features of this antibody is its high sensitivity and specificity, making it ideal for use in a wide range of experimental conditions. It has been extensively validated for use in various cell types and tissues, ensuring reliable and reproducible results.
In summary, the Anti-Human CD326/EPCAM Antibody (3-17I) is a powerful tool for studying the CD326/EPCAM protein and its role in various biological processes and diseases. Its high specificity, sensitivity, and versatility make it an essential antibody for any researcher or clinician working in the field of biotechnology and cancer research. Order now and unlock the full potential of CD326/EPCAM research.
There are no reviews yet.